Collplant Biotechnologies Ltd
NASDAQ:CLGN

Watchlist Manager
Collplant Biotechnologies Ltd Logo
Collplant Biotechnologies Ltd
NASDAQ:CLGN
Watchlist
Price: 3.44 USD 0.88%
Market Cap: 39.4m USD
Have any thoughts about
Collplant Biotechnologies Ltd?
Write Note

Collplant Biotechnologies Ltd
Total Equity

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Collplant Biotechnologies Ltd
Total Equity Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Total Equity CAGR 3Y CAGR 5Y CAGR 10Y
Collplant Biotechnologies Ltd
NASDAQ:CLGN
Total Equity
$28.3m
CAGR 3-Years
85%
CAGR 5-Years
39%
CAGR 10-Years
N/A
Kamada Ltd
NASDAQ:KMDA
Total Equity
$255.3m
CAGR 3-Years
12%
CAGR 5-Years
14%
CAGR 10-Years
13%
Enlivex Therapeutics Ltd
NASDAQ:ENLV
Total Equity
$28.6m
CAGR 3-Years
-32%
CAGR 5-Years
13%
CAGR 10-Years
N/A
Urogen Pharma Ltd
NASDAQ:URGN
Total Equity
$25.5m
CAGR 3-Years
-7%
CAGR 5-Years
-34%
CAGR 10-Years
N/A
Entera Bio Ltd
NASDAQ:ENTX
Total Equity
$6.5m
CAGR 3-Years
-37%
CAGR 5-Years
10%
CAGR 10-Years
N/A
B
Bonus Biogroup Ltd
TASE:BONS
Total Equity
â‚Ş15.4m
CAGR 3-Years
-45%
CAGR 5-Years
N/A
CAGR 10-Years
18%
No Stocks Found

Collplant Biotechnologies Ltd
Glance View

Market Cap
39.4m USD
Industry
Biotechnology

CollPlant Biotechnologies Ltd. is a regenerative medicine company, which engages in the research, development, manufacture, and marketing of medical products for tissue repair such as bioprinting of tissues and organs, and medical aesthetics. The firm provides products and technologies for broadly understood regenerative medicine, including tissue regeneration and organ production. The technology is based on plants and is based on the production of collagen type I (rhCollagen).

CLGN Intrinsic Value
15.33 USD
Undervaluation 78%
Intrinsic Value
Price

See Also

What is Collplant Biotechnologies Ltd's Total Equity?
Total Equity
28.3m USD

Based on the financial report for Dec 31, 2023, Collplant Biotechnologies Ltd's Total Equity amounts to 28.3m USD.

What is Collplant Biotechnologies Ltd's Total Equity growth rate?
Total Equity CAGR 5Y
39%

Over the last year, the Total Equity growth was -12%. The average annual Total Equity growth rates for Collplant Biotechnologies Ltd have been 85% over the past three years , 39% over the past five years .

Back to Top